Sean Bromley - Net Worth and Insider Trading
Sean Bromley Net Worth
The estimated net worth of Sean Bromley is at least $300 dollars as of 2024-09-23. Sean Bromley is the Director of Isracann Biosciences Inc and owns about 20,000 shares of Isracann Biosciences Inc (XCNQ:IPOT) stock worth over $300. Details can be seen in Sean Bromley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sean Bromley has not made any transactions after 2019-10-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sean Bromley
Sean Bromley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sean Bromley owns 1 companies in total, including Isracann Biosciences Inc (XCNQ:IPOT) .
Click here to see the complete history of Sean Bromley’s form 4 insider trades.
Insider Ownership Summary of Sean Bromley
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XCNQ:IPOT | Isracann Biosciences Inc | 2019-10-21 | Director |
Sean Bromley Latest Holdings Summary
Sean Bromley currently owns a total of 1 stock. Sean Bromley owns 20,000 shares of Isracann Biosciences Inc (XCNQ:IPOT) as of October 21, 2019, with a value of $300.
Latest Holdings of Sean Bromley
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XCNQ:IPOT | Isracann Biosciences Inc | 2019-10-21 | 20,000 | 0.02 | 300 |
Holding Weightings of Sean Bromley
Sean Bromley Form 4 Trading Tracker
According to the SEC Form 4 filings, Sean Bromley has made a total of 2 transactions in Isracann Biosciences Inc (XCNQ:IPOT) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Isracann Biosciences Inc is the acquisition of 10,000 shares on October 21, 2019, which cost Sean Bromley around $2,950.
Insider Trading History of Sean Bromley
- 1
Sean Bromley Trading Performance
GuruFocus tracks the stock performance after each of Sean Bromley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sean Bromley is 31.71%. GuruFocus also compares Sean Bromley's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sean Bromley within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sean Bromley's insider trading performs compared to the benchmark.
Performance of Sean Bromley
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 32.44 | | | | | |
| Relative Return to S&P 500(%) | 28.79 | | | | | |
Sean Bromley Ownership Network
Sean Bromley Owned Company Details
What does Isracann Biosciences Inc do?
Who are the key executives at Isracann Biosciences Inc?
Sean Bromley is the Director of Isracann Biosciences Inc.
Isracann Biosciences Inc (XCNQ:IPOT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Isracann Biosciences Inc (XCNQ:IPOT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Isracann Biosciences Inc (XCNQ:IPOT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Isracann Biosciences Inc (XCNQ:IPOT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Isracann Biosciences Inc Insider Transactions
Sean Bromley Mailing Address
Above is the net worth, insider trading, and ownership report for Sean Bromley. Currently GuruFocus does not have mailing address information for Sean Bromley.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
